Cancer Clinical Trial
Official title:
The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease
Exposure to secondhand smoke is a leading preventable cause of child morbidity and
mortality, and the adverse health consequences of secondhand smoke are magnified among
youngsters with cancer and sickle cell disease. Current methods for measuring secondhand
smoke exposure (SHSe) rely on retrospective reports over extended time periods that are
subject to recall errors and systematic inaccuracies in reporting and often do not include
the youngster as the primary informant. These methods may underestimate the extent of
cumulative SHSe and are not well suited to capturing exposure over time and across settings
where young people frequent. More appealing methods that engage youngsters to better monitor
tobacco smoke in their environment are warranted.
The study will examine the feasibility of cell phone texting to obtain measures of
secondhand smoke exposure (SHSe) in children treated for cancer or sickle cell disease
(SCD).
Children participating on this study will be asked to report on the smoking that takes place
in their presence for a period of 7 days by responding to daily texted messages sent by the
research team to their mobile phones. Rates of participation on the study, compliance with
reporting SHSe, and feedback about the technical viability and satisfaction with the texting
methods will be obtained. Parents will also be asked to report on the child's SHSe during
the same 7-day period so that child and parent reports can be compared. In addition to
quantitative child and parent reports of SHSe, child and parent questionnaire data about
attitudes, behavioral practices to control SHSe, and other socio-environmental factors will
be obtained. Individual interviews with youngsters will provide additional qualitative
information about the social context and conditions in the child's environment that maintain
or contribute to avoidance of exposure. This information will be collectively used to
develop a larger trial that will test a behavioral intervention to reduce SHSe among
youngsters with cancer and SCD and require them to monitor their SHSe using text messaging.
Measuring SHSe in these vulnerable populations and intervening to reduce their SHSe is
critical to protecting their current and long-term health.
As participation rates and compliance may differ among youngsters diagnosed with cancer and
sickle cell disease, participants will be stratified by disease group (up to 55 with cancer
and up to 55 with SCD).
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|